RBCx Launches Venture Debt to Pre-revenue, VC-backed Life Science Companies
For decades, venture-backed life science companies in the U.S. have used debt as a cost efficient way to minimize dilution on the way to their next meaningful clinical milestone. RBCx… Read More



